Polycystic ovary syndrome epidemiology and demographics: Difference between revisions
(→Gender) |
Aditya Ganti (talk | contribs) (→Age) |
||
| (11 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Polycystic ovary syndrome}} | {{Polycystic ovary syndrome}} | ||
{{CMG}} ; {{AE}} {{ADG}} | |||
{{CMG}} | |||
==Overview== | ==Overview== | ||
Polycystic ovarian syndrome (PCOS) is one of the most common [[endocrine]] disorders in [[reproductive]]-age women, with a [[prevalence]] of 4-12% in the United States. Up to 10% of women are diagnosed with PCOS. | |||
==Epidemiology and | ==Epidemiology== | ||
===Prevalence=== | |||
*Approximately 5% to 10% of women of [[reproductive]] age are affected.<ref name="pmid26426951">{{cite journal |vauthors=Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS |title=Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome |journal=Endocr. Rev. |volume=36 |issue=5 |pages=487–525 |year=2015 |pmid=26426951 |pmc=4591526 |doi=10.1210/er.2015-1018 |url=}}</ref><ref name="pmid27238627">{{cite journal |vauthors=Azziz R |title=Introduction: Determinants of polycystic ovary syndrome |journal=Fertil. Steril. |volume=106 |issue=1 |pages=4–5 |year=2016 |pmid=27238627 |doi=10.1016/j.fertnstert.2016.05.009 |url=}}</ref> | |||
*[[Prevalence]] among first-degree relatives of patients with PCOS is 25% to 50%, suggesting a strong [[inheritance]] of the syndrome; there is evidence for possible [[X-linked]] dominant transmission. | |||
==Demographics== | |||
===Age=== | ===Age=== | ||
Polycystic ovary syndrome can appear anytime from menarche until menopause but generally, is seen around menarche and is diagnosed then or in early adulthood.<ref name="pmid24435776">{{cite journal |vauthors=Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A |title=The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone |journal=Hum. Reprod. |volume=29 |issue=4 |pages=791–801 |year=2014 |pmid=24435776 |doi=10.1093/humrep/det469 |url=}}</ref> | |||
===Gender=== | ===Gender=== | ||
Polycystic ovary syndrome occurs in approximately 1 in 10 women. | |||
===Race=== | ===Race=== | ||
There is no racial predilection for polycystic ovary syndrome. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Endocrinology]] | |||
[[Category:Gynecology]] | |||
[[Category:Obstetrics]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
Latest revision as of 17:32, 18 October 2017
|
Polycystic ovary syndrome Microchapters |
|
Differentiating Polycystic ovary syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Polycystic ovary syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Polycystic ovary syndrome epidemiology and demographics |
|
FDA on Polycystic ovary syndrome epidemiology and demographics |
|
CDC on Polycystic ovary syndrome epidemiology and demographics |
|
Polycystic ovary syndrome epidemiology and demographics in the news |
|
Blogs on Polycystic ovary syndrome epidemiology and demographics |
|
Risk calculators and risk factors for Polycystic ovary syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders in reproductive-age women, with a prevalence of 4-12% in the United States. Up to 10% of women are diagnosed with PCOS.
Epidemiology
Prevalence
- Approximately 5% to 10% of women of reproductive age are affected.[1][2]
- Prevalence among first-degree relatives of patients with PCOS is 25% to 50%, suggesting a strong inheritance of the syndrome; there is evidence for possible X-linked dominant transmission.
Demographics
Age
Polycystic ovary syndrome can appear anytime from menarche until menopause but generally, is seen around menarche and is diagnosed then or in early adulthood.[3]
Gender
Polycystic ovary syndrome occurs in approximately 1 in 10 women.
Race
There is no racial predilection for polycystic ovary syndrome.
References
- ↑ Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS (2015). "Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome". Endocr. Rev. 36 (5): 487–525. doi:10.1210/er.2015-1018. PMC 4591526. PMID 26426951.
- ↑ Azziz R (2016). "Introduction: Determinants of polycystic ovary syndrome". Fertil. Steril. 106 (1): 4–5. doi:10.1016/j.fertnstert.2016.05.009. PMID 27238627.
- ↑ Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A (2014). "The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone". Hum. Reprod. 29 (4): 791–801. doi:10.1093/humrep/det469. PMID 24435776.